Explore / Clinical trial
Clinical trial

Examining the Impact of Sirolimus on Ketamine's Antidepressant Effects

Yale UniversityCompletedPhase 2Started Mar 1, 201623 enrolledUnited StatesNCT02487485

Abstract

The aim of the study is to provide insight into the impact of the immunosuppressant drug sirolimus, on the antidepressant effects of the prototypal rapid-acting antidepressant medication, ketamine.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

KetamineDepression

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.